Recently, Amini-Khoei et al. (2017) demonstrated that intracerebral administration of OXT reduced pro-inflammatory gene expression related to microglia activity, including TNF-α, IL-1β, and TLR4, in the HIP of adult animals exposed to MS [128]. This evidence concerns the gene IL1B and myeloid sarcoma.